Evaluating an AI tool for nursing starts with a precise intended use. A tool that drafts a note, predicts a risk, or prioritizes a work queue poses different questions. The evaluation should identify the decision or task, the users, the patients, and the consequence of an incorrect output.
A product demonstration shows what a tool can do under selected conditions. It does not establish safety, effectiveness, or workload savings in the local clinical environment.
Define the comparison
Describe the current workflow and the problem to be improved. Decide what a meaningful improvement would look like and what must not become worse. For a documentation tool, that may mean preserving clinically important facts while reducing total documentation effort. For a prioritization tool, it may mean identifying the right patients without creating unmanageable false alerts.
AHRQ's health IT evaluation toolkit recommends aligning measures with project goals, stakeholder needs, and what can feasibly be measured. Include patient and frontline nursing perspectives when choosing those measures.
Examine the evidence and data
Ask for the intended population and setting, the version evaluated, the data used, and the reference against which performance was judged. Distinguish development testing from evaluation in a new setting. Check whether reported results apply to the actual feature being purchased and the way it will be used.
For generative tools, review unsupported additions, omissions, and privacy risks. For predictive tools, examine relevant error types and performance across patient groups. A claim of high accuracy without a defined denominator, outcome, and error analysis is not enough to guide a clinical decision.
NIST's AI Risk Management Framework organizes risk work around governance, context, measurement, and management. It is a voluntary framework; using it does not itself validate a healthcare product.
Illustrative test plan
An illustrative team evaluating an AI handoff summary creates cases containing a changed care plan, an unresolved concern, conflicting dates, and a meaningful negative finding. Nurses compare the draft with the source material and record whether it preserves those distinctions.
The team also measures review and correction time. A draft produced quickly but requiring extensive checking may not save time overall. The example is a proposed evaluation method, not an observed outcome or a universal test set.
Decide who can stop the tool
Before a pilot, assign a clinical owner, technical support, privacy review, training, incident reporting, and stop criteria. Define how staff will work when the tool is unavailable or suspended. The SAFER organizational-responsibilities guide calls for shared responsibility among healthcare organizations and AI and EHR developers.
Reassess after changes to the model, data feeds, interface, or intended use. A successful evaluation of one version does not automatically apply to the next.
The decision to adopt should state what has been demonstrated, what remains uncertain, and how the organization will detect harm or degraded performance.
Include bias in clinical algorithms when deciding which people and settings to include in an evaluation.
Related
AI Documentation Tools in Nursing
Sources
-
NIST AI Risk Management Framework Core (accessed 2026-09-17).
-
NIST: Generative Artificial Intelligence Profile (accessed 2026-09-17).
-
AHRQ: Health IT Evaluation Toolkit (accessed 2026-09-17).
-
SAFER: Organizational Responsibilities (accessed 2026-09-17).